Journal of Pharmaceutical Sciences

Cover image for Journal of Pharmaceutical Sciences

April 2009

Volume 98, Issue 4

Pages 1201–1601

  1. Commentaries

    1. Top of page
    2. Commentaries
    3. Global Health Commentary
    4. Reviews
    5. Research Articles
    1. Overlooking subvisible particles in therapeutic protein products: Gaps that may compromise product quality (pages 1201–1205)

      John F. Carpenter, Theodore W. Randolph, Wim Jiskoot, Daan J.A. Crommelin, C. Russell Middaugh, Gerhard Winter, Ying-Xin Fan, Susan Kirshner, Daniela Verthelyi, Steven Kozlowski, Kathleen A. Clouse, Patrick G. Swann, Amy Rosenberg and Barry Cherney

      Version of Record online: 14 AUG 2008 | DOI: 10.1002/jps.21530

    2. You have free access to this content
      Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium (pages 1206–1219)

      B. Chuasuwan, V. Binjesoh, J.E. Polli, H. Zhang, G.L. Amidon, H.E. Junginger, K.K. Midha, V.P. Shah, S. Stavchansky, J.B. Dressman and D.M. Barends

      Version of Record online: 27 AUG 2008 | DOI: 10.1002/jps.21525

  2. Global Health Commentary

    1. Top of page
    2. Commentaries
    3. Global Health Commentary
    4. Reviews
    5. Research Articles
    1. Passing the civilization test (pages 1220–1222)

      Joseph T. Cunliffe Sr.

      Version of Record online: 24 NOV 2008 | DOI: 10.1002/jps.21614

  3. Reviews

    1. Top of page
    2. Commentaries
    3. Global Health Commentary
    4. Reviews
    5. Research Articles
    1. Effects of glycosylation on the stability of protein pharmaceuticals (pages 1223–1245)

      Ricardo J. Solá and Kai Griebenow

      Version of Record online: 25 JUL 2008 | DOI: 10.1002/jps.21504

    2. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life (pages 1246–1277)

      William F. Weiss IV, Teresa M. Young and Christopher J. Roberts

      Version of Record online: 6 AUG 2008 | DOI: 10.1002/jps.21521

    3. Vaccine adjuvants: Current challenges and future approaches (pages 1278–1316)

      Jennifer H. Wilson-Welder, Maria P. Torres, Matt J. Kipper, Surya K. Mallapragada, Michael J. Wannemuehler and Balaji Narasimhan

      Version of Record online: 14 AUG 2008 | DOI: 10.1002/jps.21523

  4. Research Articles

    1. Top of page
    2. Commentaries
    3. Global Health Commentary
    4. Reviews
    5. Research Articles
    1. Biotechnology

      Structural stability of vault particles (pages 1376–1386)

      Reza Esfandiary, Valerie A. Kickhoefer, Leonard H. Rome, Sangeeta B. Joshi and C. Russell Middaugh

      Version of Record online: 6 AUG 2008 | DOI: 10.1002/jps.21508

    2. Solid state chemistry of proteins IV. what is the meaning of thermal denaturation in freeze dried proteins? (pages 1387–1399)

      Michael J. Pikal, Daniel Rigsbee and Michael J. Akers

      Version of Record online: 14 AUG 2008 | DOI: 10.1002/jps.21517

    3. Evaluation of the effect of non-B DNA structures on plasmid integrity via accelerated stability studies (pages 1400–1408)

      S.C. Ribeiro, G.A. Monteiro and D.M.F. Prazeres

      Version of Record online: 8 SEP 2008 | DOI: 10.1002/jps.21503

    4. Drug Discovery Interface

      Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines (pages 1409–1425)

      Nikhil M. Vad, Garret Yount, Dan Moore, Jon Weidanz and Majid Y. Moridani

      Version of Record online: 29 AUG 2008 | DOI: 10.1002/jps.21505

    5. Pharmaceutics, Preformulation and Drug Delivery

      NMR search for polymorphic phase transformations in chlorpropamide form-A at high pressures (pages 1426–1437)

      J. Wąsicki, D.P. Kozlenko, S.E. Pankov, P. Bilski, A. Pajzderska, B.C. Hancock, A. Medek, W. Nawrocik and B.N. Savenko

      Version of Record online: 11 JUL 2008 | DOI: 10.1002/jps.21471

    6. Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: Formulations of mithramycin and bioactivity (pages 1452–1462)

      Einat Cohen-Sela, Shay Teitlboim, Michael Chorny, Nickolay Koroukhov, Haim D. Danenberg, Jianchuan Gao and Gershon Golomb

      Version of Record online: 14 AUG 2008 | DOI: 10.1002/jps.21527

    7. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties (pages 1463–1475)

      Gabrielle Pilcer, Francis Vanderbist and Karim Amighi

      Version of Record online: 27 AUG 2008 | DOI: 10.1002/jps.21545

    8. Pharmaceutical Technology

      Pair distribution function X-ray analysis explains dissolution characteristics of felodipine melt extrusion products (pages 1476–1486)

      K. Nollenberger, A. Gryczke, Ch. Meier, J. Dressman, M.U. Schmidt and S. Brühne

      Version of Record online: 27 AUG 2008 | DOI: 10.1002/jps.21534

    9. On-line monitoring of pharmaceutical production processes using Hidden Markov Model (pages 1487–1498)

      Hui Zhang, Zhuangde Jiang, J.Y. Pi, H.K. Xu and R. Du

      Version of Record online: 27 AUG 2008 | DOI: 10.1002/jps.21535

    10. Pharmacokinetics, Pharmacodynamics and Drug Metabolism

      Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in vitro intestinal parameters (pages 1532–1544)

      Masahiro Nomoto, Tomoko Tatebayashi, Jun Morita, Hisashi Suzuki, Kazumasa Aizawa, Tohru Kurosawa and Izumi Komiya

      Version of Record online: 6 AUG 2008 | DOI: 10.1002/jps.21510

    11. Pharmacokinetic and pharmacodynamic evaluation of site-specific PEGylated glucagon-like peptide-1 analogs as flexible postprandial-glucose controllers (pages 1556–1567)

      Su Young Chae, Young Goo Chun, Seulki Lee, Cheng-Hao Jin, Eun Seong Lee, Kang Choon Lee and Yu Seok Youn

      Version of Record online: 14 AUG 2008 | DOI: 10.1002/jps.21532

    12. Scintigraphic study to investigate the effect of food on a HPMC modified release formulation of UK-294,315 (pages 1568–1576)

      J. Davis, J. Burton, A.L. Connor, R. MacRae and I.R. Wilding

      Version of Record online: 27 AUG 2008 | DOI: 10.1002/jps.21507

    13. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: Characterization and pharmacokinetics in rats (pages 1577–1586)

      May P. Xiong, Jaime A. Yáñez, Glen S. Kwon, Neal M. Davies and M. Laird Forrest

      Version of Record online: 27 AUG 2008 | DOI: 10.1002/jps.21509

SEARCH

SEARCH BY CITATION